Genentech, Inc. Posts $931 Million 4Q Profit, an Industrial Info News Alert

January 21, 2009 |

1 min read

SUGAR LAND, TX--(Marketwire - January 21, 2009) -

Highlighted Links

Researched by Industrial Info Resources (Sugar Land, Texas) -- Genentech Incorporated (NYSE:DNA) (San Francisco, California) recently announced a fourth-quarter 2008 net income of $931 million, up 47% compared with $632 million in the same period of 2007. Sales for the quarter rose 13% to $2.5 billion, compared with $2.2 billion in the fourth quarter of 2007. Industrial Info is tracking two active Genentech projects worth $300 million as part of our Pharmaceutical Tracker - Online Database. The larger of the two projects is a grassroot biotherapeutic fill and finish plant in Hillsboro, Oregon. Hillsboro is one of three locations that Genentech has targeted to ramp up manufacturing, Chairman and CEO Arthur Levinson said.

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at http://www.industrialinfo.com/showNews.jsp?newsitemID=143058, or browse other breaking industrial news stories at www.industrialinfo.com.

Industrial Info Resources (IIR) is a marketing information service specializing in industrial process, energy and financial related markets with products and services ranging from industry news, analytics, forecasting, plant and project databases, as well as multimedia services. For more information send inquiries to pharmabiogroup@industrialinfo.com or visit us at www.industrialinfo.com.